Skip to main content
OpenTrials

Clinical trial condition

alpha 1-Antitrypsin Deficiency

Explore clinical trials studying alpha 1-Antitrypsin Deficiency. Study availability and eligibility vary by location and protocol.

100 public trials 18 recruiting studies
Refine in advanced search Browse all conditions

alpha 1-Antitrypsin Deficiency trial results

Completed

GLASSIA Safety, Immunogenicity, and Bronchoalveolar Lavage Study

NCT02525861

Conditions
Alpha1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • Arizona Board of Regents, University of Arizona Tucson, Arizona, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Cedars Sinai Medical Center, Division of Pulmonary and Critical Care Medicine Los Angeles, California, United States
  • University of California Davis Health System Sacramento, California, United States
View all 18 locations
View Trial Details
Completed

GLASSIA Infusion Rate Study

NCT01651351

Conditions
Alpha1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +11 more
Locations
  • Overland Park, Kansas, United States
View Trial Details
Completed

Pharmacokinetic Study of ARALAST (Human Alpha1- PI)

NCT00242385

Conditions
Alpha 1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • Adelaide, South Australia, Australia
  • Woodville, South Australia, Australia
  • Fitzroy, Victoria, Australia
  • Nedlands, Western Australia, Australia
View Trial Details
Completed

Efficacy and Safety Study of Augmentation Therapy With ARALAST Fraction IV-1 (Human Alpha 1 - Proteinase Inhibitor)

NCT00396006

Conditions
Alpha 1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • Adelaide, South Australia, Australia
  • Melbourne, Victoria, Australia
  • Nedlands, Western Australia, Australia
  • Otahuhu, Auckland, New Zealand
View Trial Details
Completed

Safety Study of an Aerosolized, Recombinant Alpha 1-Antitrypsin in Subjects With Alpha 1-Antitrypsin Deficiency

NCT00161707

Conditions
Alpha1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • National Jewish Medical and Research Center Denver, Colorado, United States
  • Shands Hospital at the University of Florida Gainesville, Florida, United States
  • Cleveland Clinic Foundation, Department of Pulmonary and Critical Care Medicine Cleveland, Ohio, United States
  • The University of Texas Health Science Center at Tyler Tyler, Texas, United States
View Trial Details
Completed

Alpha-1 Foundation Research Registry

NCT00499941

Conditions
Alpha 1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • Medical University of South Carolina. Division of Pulmonary and Critical Care Medicine Charleston, South Carolina, United States
View Trial Details
Completed

Efficacy/Safety of HA Inhalation Solution for Hereditary Emphysema in Patients With Alpha-1 Antitrypsin Deficiency

NCT03114020

Conditions
Alpha 1-Antitrypsin Deficiency, Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +13 more
Locations
  • University of Miami Hospital Miami, Florida, United States
  • Pulmonary Health Physicians, PC Fayetteville, New York, United States
  • Medical University of South Carolina Charleston, South Carolina, United States
  • University of Texas Health Science Center Tyler, Texas, United States
View Trial Details

Related conditions